Back to MORGAN STANLEY MORGAN STANLEY

CYTKCYTK
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in CYTOKINETICS INC

MORGAN STANLEY holds 1.5M shares of CYTK (CYTOKINETICS INC), worth $99.2M as of 2026-Q1. The position was increased (+18.9% shares). CYTK represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$99.2M

Current Shares

1.5M

Total Value Change

+$39.3M

Total Shares Change

+399,401

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.5M
+18.9%
$99.2M0.0%$60.72
35
2025-Q4
Decreased
1.3M
-16.8%
$80.4M0.0%$61.37
0
2025-Q3
Increased
1.5M
+36.0%
$83.6M0.0%$53.89
39
2025-Q2
Increased
1.1M
+10.5%
$36.9M0.0%$33.16
32
2025-Q1
Decreased
1M
-19.3%
$40.7M0.0%$43.19
0
2024-Q4
Increased
1.3M
+7.2%
$58.9M0.0%$47.15
32
2024-Q3
Increased
1.2M
+5.7%
$61.7M0.0%$52.34
31
2024-Q2
New
1.1M
-
$59.9M0.0%$54.18
41

Other major holders of CYTK: BlackRock Finance, Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used